Pen or syringe? study tests easier pasireotide delivery
NCT ID NCT07312643
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving the drug pasireotide with a reusable pen works as well as using a traditional syringe. Forty healthy adults received a single dose by both methods to compare how the drug enters the body and if it is safe. The goal is to find a more convenient way for patients to take this medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pasireotide
What this could lead to
If successful, this could show that a reusable pen is a safe and effective way to deliver pasireotide, potentially making it easier for patients to use.
What could go wrong
This is an early-phase study in healthy volunteers, not patients. It only tests how the drug is absorbed, not whether it works for any disease. The pen may not perform as well as the syringe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nuvisan GmBH
Neu-Ulm, 89231, Germany